Development of Novel Mutation-Specific Droplet Digital PCR Assays Detecting TERT Promoter Mutations in Tumor and Plasma Samples
- 1 March 2019
- journal article
- research article
- Published by Elsevier in The Journal of Molecular Diagnostics
- Vol. 21 (2) , 274-285
Abstract
No abstract availableKeywords
Funding Information
- NIH (R21CA198495, UH2CA206124, CA016087)
This publication has 22 references indexed in Scilit:
- Current and Emerging Applications of Droplet Digital PCR in OncologyMolecular Diagnosis & Therapy, 2017
- Liquid biopsies come of age: towards implementation of circulating tumour DNANature Reviews Cancer, 2017
- P2.03b-030 Retrospective Review Clinical Use of a cfDNA Blood Test for Identification of Targetable Molecular Alterations in Patients with Lung CancerJournal of Thoracic Oncology, 2017
- Association Between Plasma Genotyping and Outcomes of Treatment With Osimertinib (AZD9291) in Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2016
- Prospective Validation of Rapid Plasma Genotyping for the Detection ofEGFRandKRASMutations in Advanced Lung CancerJAMA Oncology, 2016
- Quantitative Cell-Free Circulating BRAFV600E Mutation Analysis by Use of Droplet Digital PCR in the Follow-up of Patients with Melanoma Being Treated with BRAF InhibitorsClinical Chemistry, 2015
- TERT promoter mutations in cancer developmentCurrent Opinion in Genetics & Development, 2014
- Highly Recurrent TERT Promoter Mutations in Human MelanomaScience, 2013
- High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy NumberAnalytical Chemistry, 2011
- Circulating free DNA in plasma or serum as biomarker of carcinogenesis: Practical aspects and biological significanceMutation Research - Reviews in Mutation Research, 2007